Instant Report

Date: 12-Jan-2021

JB Chemicals Receives US FDA Approval For Loratadine Tablets

J B Chemicals & Pharmaceuticals Limited has received approval from US Food and Drug Administration (FDA) for loratadine tablets USP 10 mg for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use.

This product is generic version of Clartin tablet in the same strength of Bayer Healthcare LLC.

The company expects to commercialize this product in Q1 of FY 2021-22 and is expected to improve company's US sales